Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of pharmacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx.
Scott Davis is the CEO of Ekso Bionics, an innovative medical device company making wearable exoskeletons for use in construction but perhaps, more importantly, to help people contending with spinal cord injury.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In this episode, the CEO of Lumen talks about the sleek consumer device and why he is at a b-to-b healthcare conference.
Anne Osdoit, CEO of Moon Surgical, explains how the Maestro System may be expanding the surgical robotics pie by bringing the capability to newer markets and how surgical robotics do not have to break the bank.
In the last episode of the year, Wrobel, CEO of an Indiana-based federally qualified health center, describes how a survey helped her and her community workers understand exactly how confident her patients are in managing their own care and the best way to help them with the ultimate goal of improving overall health equity.
Dr. Brian Clear, an addiction treatment physician and chief medical officer of Bicycle Health, believes that telemedicine is one way to improve access and reduce the inequities inherence in addiction treatment. The other is education.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Season 4 launches with a focus on health equity and a conversation with Dr. Alisahah Jackson, system vice president of population health innovation and policy at CommonSpirit Health.
Rich Horgan believes that there's an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases.
The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner.
Transformations in the Life Sciences is the focus of the second season of the MedCity Pivot Podcast. My personal journey as a caregiver of a cancer patient made me choose Dr. Sumanta Pal, co-director of the City of Hope's Liver Cancer program as a guest after he co-authored an interesting study on immunotherapy that was published in the Lancet.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
I interview Punit Singh Soni, CEO of Suki and Niall O'Connor, CTO, Cohere Health to evaluate two areas where AI can have an outsize impact: clinical documentation and prior authorization.
A conversation with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab about responsible AI.
Season 2 of our MedCity Pivot Podcast launches today with a conversation about how AI can be leveraged to transform precision medicine.
Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company's Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid.
Steve Driver is an interventional cardiologist as well as medical director of digital therapeutics at Advocate Aurora Health, which last year merged with Atrium Health. In this episode, he talked about a pilot involving Omada Health targeting a prediabetes population, among other things.